BDBM453027 (2S,3S,4R,5R)-2-((S)-2- chloro-4,7-dihydro-5H- thieno[2,3-c]pyran-7-yl)-5-(4- methyl-7H-pyrrolo[2,3- d]pyrimidin-7- yl)tetrahydrofuran-3,4-diol::US10711007, Example 89::US11214574, Ex# 89::US11254683, Example 89

SMILES Cc1ncnc2n(ccc12)[C@@H]1O[C@@H]([C@@H](O)[C@H]1O)[C@@H]1OCCc2cc(Cl)sc12

InChI Key InChIKey=RGEFRBMOBQDZBB-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 453027   

TargetProtein arginine N-methyltransferase 5(Human)
Prelude Therapeutics

US Patent
LigandPNGBDBM453027((2S,3S,4R,5R)-2-((S)-2- chloro-4,7-dihydro-5H- thi...)
Affinity DataIC50: 15.7nMAssay Description:Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (20 mM Tris-HCl, pH 8.0,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2021
Entry Details
Go to US Patent

TargetMethylosome protein 50/Protein arginine N-methyltransferase 5(Human)
Prelude Therapeutics

US Patent
LigandPNGBDBM453027((2S,3S,4R,5R)-2-((S)-2- chloro-4,7-dihydro-5H- thi...)
Affinity DataIC50: 15.7nMAssay Description:Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (20 mM Tris-HCl, pH 8.0,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/8/2022
Entry Details
Go to US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Prelude Therapeutics

US Patent
LigandPNGBDBM453027((2S,3S,4R,5R)-2-((S)-2- chloro-4,7-dihydro-5H- thi...)
Affinity DataIC50: 15.7nMAssay Description:Compounds were solubilized and 3-fold diluted in 100% DMSO. These diluted compounds were further diluted in the assay buffer (20 mM Tris-HCl, pH 8.0,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/19/2022
Entry Details
Go to US Patent